MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ijrobp.2020.12.025

Медицинская библиотека · International journal of radiation oncology, biology, physics · 2020

Radiation Therapy Alone for Human Papillomavirus-Related Squamous Cell Carcinoma of the Oropharynx: A Single-Arm, Phase 2 Study.

Takemoto Norihiko, Seo Yuji, Nakahara Susumu, Yoshioka Yasuo, Teshima Teruki, Fujii Takashi, Isohashi Fumiaki, Otani Keisuke, Yoshii Tadashi, Takenaka Yukinori, Suzuki Motoyuki, Fukusumi Takahito, Hanamoto Atsushi, Yasui Toshimichi, Michiba Takahiro, Yamamoto Yoshifumi, Shimamoto Shigetoshi, Tanaka Hidenori, Tatsumi Mitsuaki, Ogawa Kazuhiko, Inohara Hidenori

Клиническое исследование II фазыСтатьяМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

PURPOSE: Human papillomavirus (HPV)-related squamous cell carcinoma of the oropharynx (OPSCC) is extremely radiosensitive. Radiation therapy plus high-dose cisplatin remains the standard of care but causes long-term toxicity. Treatment deintensification approaches that reduce toxicity while maintaining survival are desirable for HPV-related OPSCC.

METHODS AND MATERIALS: We conducted a single-arm, multicenter, phase 2 trial. Patients with newly diagnosed, biopsy-proven, American Joint Committee on Cancer (seventh edition) stage III or IV OPSCC positive for both p16 and HPV DNA were eligible. Patients with T4, N3, or T1N1 disease were excluded. Smoking history was not included in eligibility criteria. Patients received intensity modulated radiation therapy (IMRT) of 70 Gy in 35 fractions or 70.4 Gy in 32 fractions without chemotherapy. The primary endpoint was complete response or complete metabolic response 10 weeks after IMRT completion.

RESULTS

Between September 13, 2013, and November 15, 2016, 39 patients were enrolled according to a 2-stage Simon design. Twenty-three patients (59%) had smoked for more than10 pack-years. Thirty-six patients (92%) had tumors genotyped as HPV16. Thirty-seven patients (95%) received full-dose radiation therapy and 35 (90%) had complete response or complete metabolic response. Median follow-up was 51 months (interquartile range, 41-63 months). One patient (3%) had regional recurrence and 3 (8%) had distant metastasis. One patient died of disease. The 2-year progression-free survival rate was 94% (95% CI, 81%-99%), and the 2-year overall survival rate was 100%. Common grade 3 adverse events during IMRT included mucositis in 10 patients (26%) and dysphagia in 7 patients (18%). No patients were dependent on a feeding tube at 1 month after IMRT completion. No grade 3 or 4 late adverse events were observed.

CONCLUSIONS

IMRT alone is associated with excellent response as well as reduced toxicity and could be a treatment option for carefully selected patients with locally advanced "true" HPV-related OPSCC. Further studies are warranted.

Для цитирования: Takemoto Norihiko, Seo Yuji, Nakahara Susumu, Yoshioka Yasuo, Teshima Teruki, Fujii Takashi, Isohashi Fumiaki, Otani Keisuke, Yoshii Tadashi, Takenaka Yukinori, Suzuki Motoyuki, Fukusumi Takahito, Hanamoto Atsushi, Yasui Toshimichi, Michiba Takahiro, Yamamoto Yoshifumi, Shimamoto Shigetoshi, Tanaka Hidenori, Tatsumi Mitsuaki, Ogawa Kazuhiko, Inohara Hidenori. Radiation Therapy Alone for Human Papillomavirus-Related Squamous Cell Carcinoma of the Oropharynx: A Single-Arm, Phase 2 Study.. International journal of radiation oncology, biology, physics. 2020. DOI: 10.1016/j.ijrobp.2020.12.025.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.